Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2017; 23(14): 2625-2634
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2625
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2625
Upper gastrointestinal cancer burden in Hebei Province, China: A population-based study
Dao-Juan Li, Di Liang, Deng-Gui Wen, Jing Jin, Yu-Tong He, Cancer Institute, The Fourth Hospital of Hebei Medical University/The Tumour Hospital of Hebei Province, Shijiazhuang 050011, Hebei Province, China
Guo-Hui Song, Cixian Cancer Institute, Cixian 056500, Hebei Province, China
Yong-Wei Li, Shexian Cancer Institute, Shexian 056400, Hebei Province, China
Author contributions: He YT contributed to the study conception and design; Li DJ, Liang D, Song GH, Li YW and Wen DG contributed to the acquisition of data; Li DJ, Liang D, Jin J and He YT contributed to the data analysis and interpretation; Li DJ contributed to the drafting of the manuscript; Li DJ, Jin J and He YT contributed to critical revision of the manuscript.
Institutional review board statement: All procedures involving human participants were performed in accordance with the ethical standards and with the 2013 Helsinki declaration and its later amendments. The study was reviewed and approved by the Cancer Institute, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Informed consent statement: All study participants or their legal guardian provided informed written consent prior to study enrolment.
Conflict-of-interest statement: The authors declare that there are no conflicts of interest related to this study.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Yu-Tong He, The Fourth Hospital of Hebei Medical University/The Tumour Hospital of Hebei Province, No.12, Jiankang Road, Shijiazhuang 050011, Hebei Province, China. hytong69@yahoo.com
Telephone: +86-311-86095613 Fax: +86-311-86095613
Received: November 2, 2016
Peer-review started: November 2, 2016
First decision: January 19, 2017
Revised: January 22, 2017
Accepted: February 16, 2017
Article in press: February 16, 2017
Published online: April 14, 2017
Peer-review started: November 2, 2016
First decision: January 19, 2017
Revised: January 22, 2017
Accepted: February 16, 2017
Article in press: February 16, 2017
Published online: April 14, 2017
Core Tip
Core tip: This study is the first to examine the incidence and mortality trends of UGIC in Hebei Province. Data were collected from 21 population-based cancer registries covering 15.25% of the total population of Hebei Province in 2013. An age-period-cohort model was established to analyse the incidence rate of UGIC in a high-risk area of Hebei Province (Cixian). Additionally, we established the grey system model to predict the mortality rates of UGIC in high-risk areas of Hebei Province (Cixian and Shexian). The aim of the study was to provide epidemiological evidence for developing strategies for UGIC prevention and control.